Cystatin c proteoforms in chronic kidney disease

HIGHLIGHTS

• who: Helene Dahl and colleagues from the Department of Clinical Medicine, Centre for Nutrition, University of Bergen, Bergen, Norway, Bevital AS have published the research work: Cystatin C proteoforms in chronic kidney disease, in the Journal: PLOS ONE of 11/05/2021
• what: It was therefore the aim of this study to measure proteoforms of CysC in patients with various stages of CKD and to relate these proteoforms to disease severity, mode of treatment, and eGFR. The study showed that the concentration of proteoforms of CysC increased with decreasing renal function, however, the distribution of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.